Universal CARs, universal T cells, and universal CAR T cells

Currently, the two approved T cell products with chimeric antigen receptors (CAR) are from autologous T cells. These CAR T cells approved for clinical use must be generated on a custom-made basis. This case-by-case autologous T cell production platform remains a significant limiting factor for large...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Juanjuan, Lin, Quande, Song, Yongping, Liu, Delong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257951/
https://www.ncbi.nlm.nih.gov/pubmed/30482221
http://dx.doi.org/10.1186/s13045-018-0677-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257951/
https://www.ncbi.nlm.nih.gov/pubmed/30482221
http://dx.doi.org/10.1186/s13045-018-0677-2

Ejemplares similares